At one point yesterday, Liberator Medical (NYSEMKT:LBMH) dropped over 33% on no news. It closed at 4.68, and throughout it all, we have continued to hold onto our position in the company, which we have followed closely since 2010. We do not see any changes in the business model that make us concerned, and instead, only see continued improvement. Our thesis from the prior article before is still intact, and we urge readers to take a closer look at the business and make an educated decision for themselves.
When we last mentioned LBMH (article here), the stock was trading at $2/share and valued at 4x EV/EBITDA. In the last few months, LBMH became listed on the...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|